From a healthcare AI discussion to a Wedbush closing party, Pasadena's October slate courts investors across six events.

Meta showed off featherlight VR glasses and a keychain AI gadget, betting wearables will replace your phone.

Dr. Joseph Gonzalez brought rocket-engineering experience to a University of Illinois classroom, and he's not done reaching for space.

PubKey DC's upcoming SMR-tini-themed bash has 900 approved RSVPs as Virginia debates data center power costs.

Starting Saturday, guests can hang in a portaledge tent or scale real rock walls — all included with regular admission.

A working paper found 51% of Kalshi's analyzed volume clustered in oddly identical trade sizes. Kalshi says it's just liquidity incentives.

Three patients who nearly died from heart and lung failure returned to reunite with the Kansas City ICU staff who treated them.

A Plymouth man's early diagnosis put him inside a Henry Ford program with over 16,000 robotic prostate surgeries on record.

Stanford senior Billy Ramirez says he was upset to find himself digitally altered in his own dining-hall photo.

Applied Atomics is converting an old seafood and molasses warehouse on Chartres Street into offices and a reactor training center.

The same Mumbai manufacturer's chlorthalidone tablets have now failed FDA testing twice since June, raising fresh red flags.

Blockchain.com already sells tokenized stocks in Europe and won't say how many customers have bought in.

UCSF researchers traced how stiff, dense breast tissue recruits immune cells that release DNA-damaging chemicals, a step toward new prevention drugs.